Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NKGen Biotech ( (NKGN) ) just unveiled an update.
NKGen Biotech, Inc. is experiencing a significant change in its leadership structure as directors Michael Klowden, Sangwoo Park, and Kathleen Scott have announced their resignations, effective as of September 29, 2024. Their departure, which is not due to any disputes, will coincide with the first anniversary of their directorship and the company’s public listing. This will temporarily reduce the board from five to two directors and each committee from three to one member. The company is actively seeking replacements within 180 days and is considering reappointing Klowden and Scott.
Find detailed analytics on NKGN stock on TipRanks’ Stock Analysis page.
